2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline has been researched along with Liver Neoplasms in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.14) | 18.7374 |
1990's | 6 (42.86) | 18.2507 |
2000's | 7 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bendaly, J; Hein, DW; Metry, KJ; Neale, JR; Pierce, WM; Smith, NB | 1 |
Calvisi, DF; Conner, EA; Factor, VM; Ladu, S; Thorgeirsson, SS | 1 |
Chubachi, H; Imanishi, H; Inoue, Y; Komasa, Y; Mizoguchi, T; Nakano, M; Takekoshi, H | 1 |
Fukushima, S; Funae, Y; Kang, JS; Kinoshita, A; Kushida, M; Morimura, K; Puatanachokchai, R; Wanibuchi, H; Wei, M | 1 |
Fukushima, S; Hayashi, S; Kinoshita, A; Morimura, K; Nishikawa, T; Nishikawa-Ogawa, M; Wanibuchi, H; Yano, Y | 1 |
Ban, H; Hirata, A; Imai, T; Masegi, T; Nishigaki, R; Sakai, H; Takasu, S; Tatematsu, M; Totsuka, Y; Tsukamoto, T; Wakabayashi, K; Yanai, T | 1 |
Fukushima, S; Kang, JS; Mori, S; Morimura, K; Murai, T; Totsuka, Y; Wanibuchi, H | 1 |
Katami, M; Kurosaka, R; Kushida, H; Nagao, M; Sato, H; Wakabayashi, K | 1 |
Cui, L; Hasegawa, R; Hirose, M; Ito, N; Kato, T; Kobayashi, Y; Konishi, Y; Nakae, D; Shirai, T; Yaono, M | 1 |
Adamson, RH; Davis, CD; Schut, HA; Snyderwine, EG; Thorgeirsson, SS | 1 |
Adamson, RH; Dalgard, DW; Farb, A; Snyderwine, EG; Sugimura, T; Takayama, S; Thorgeirsson, SS; Thorgeirsson, UP; Virmani, R | 1 |
Darroudi, F; Knasmüller, S; Kundi, M; Land, SJ; Parzefall, W; Sanyal, R; Schwab, CE; Wang, CY | 1 |
Fukushima, S; Hakoi, K; Hasegawa, R; Ito, N; Iwasaki, S; Nagao, M; Shirai, T; Sugimura, T; Takaba, K; Wakabayashi, K | 1 |
Hasegawa, H; Kato, T; Ohgaki, H; Sato, S; Sugimura, T; Takayama, S | 1 |
14 other study(ies) available for 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline and Liver Neoplasms
Article | Year |
---|---|
Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline.
Topics: Acetylation; Animals; Animals, Congenic; Arylamine N-Acetyltransferase; Carcinogens; Colonic Neoplasms; Deoxyguanosine; DNA Adducts; Female; Gene Targeting; Genetic Predisposition to Disease; Imidazoles; Liver Neoplasms; Mutagens; Polymorphism, Genetic; Quinoxalines; Rats; Rats, Inbred F344; Rats, Inbred WKY; Time Factors | 2009 |
Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.
Topics: alpha-Fetoproteins; Animals; beta Catenin; Cell Cycle Proteins; Cytoskeletal Proteins; Disease Models, Animal; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Gene Deletion; Gene Frequency; Genes, myc; Genomic Instability; Liver Neoplasms; Loss of Heterozygosity; Mice; Mice, Transgenic; Mutation; Phenotype; Quinoxalines; Trans-Activators; Transcription Factors; Transforming Growth Factor alpha | 2004 |
Suppression of glutathione S-transferase placental form-positive foci development in rat hepatocarcinogenesis by Chlorella pyrenoidosa.
Topics: Animals; Body Weight; Chlorella; Diet; Diethylnitrosamine; Eating; Glutathione Transferase; Immunohistochemistry; Isoenzymes; Liver; Liver Neoplasms; Male; Organ Size; Quinoxalines; Rats; Rats, Inbred F344; Treatment Outcome | 2005 |
Dose-dependence of promotion of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis by ethanol: evidence for a threshold.
Topics: Adenoma; Administration, Oral; Animals; Carcinogens; Carcinoma, Hepatocellular; Cell Proliferation; Cytochrome P-450 CYP2E1; DNA Damage; Dose-Response Relationship, Drug; Enzyme Induction; Ethanol; Liver Neoplasms; Male; Quinoxalines; Rats; Rats, Inbred F344; RNA, Messenger | 2005 |
N-acetylcysteine and S-methylcysteine inhibit MeIQx rat hepatocarcinogenesis in the post-initiation stage.
Topics: Acetylcysteine; Animals; Anticarcinogenic Agents; Carcinogens; Cell Proliferation; Cysteine; Down-Regulation; Glutathione Transferase; Insulin-Like Growth Factor I; Liver Neoplasms; Nitric Oxide Synthase Type II; Placenta; Quinoxalines; Rats; Silver Staining; Time Factors | 2006 |
Carcinogenic risk of heterocyclic amines in combination - assessment with a liver initiation model.
Topics: Amines; Animals; Carcinogens; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; DNA, Complementary; Glutathione Transferase; Hepatocytes; Heterocyclic Compounds; Imidazoles; Liver; Liver Neoplasms; Male; Oligonucleotide Array Sequence Analysis; Quinoxalines; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; Risk | 2008 |
Evidence of a threshold-effect for 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline liver carcinogenicity in F344/DuCrj rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenoma, Liver Cell; Administration, Oral; Animal Feed; Animals; Carcinogens; Carcinoma, Hepatocellular; Deoxyguanosine; DNA Adducts; Dose-Response Relationship, Drug; Glutathione Transferase; Liver; Liver Neoplasms; Longevity; Male; No-Observed-Adverse-Effect Level; Precancerous Conditions; Quinoxalines; Rats; Rats, Inbred F344 | 2008 |
Dose-response study of MeIQx carcinogenicity in F344 male rats.
Topics: Animals; Carcinogens; Female; Liver Neoplasms; Male; Neoplasms, Experimental; Quinoxalines; Rats; Rats, Inbred F344; Skin Neoplasms | 1994 |
Dose-dependent induction of 8-hydroxyguanine and preneoplastic foci in rat liver by a food-derived carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, at low dose levels.
Topics: Animals; Body Weight; Carcinogens; Diet; Glutathione Transferase; Guanine; Liver; Liver Neoplasms; Male; Organ Size; Precancerous Conditions; Quinoxalines; Rats; Rats, Inbred F344 | 1996 |
Possible relationship between tissue distribution of DNA adducts and genotoxicity of food-derived heterocyclic amines.
Topics: Amines; Animals; Carcinoma, Hepatocellular; Cattle; Cooking; DNA Adducts; Fishes; Heterocyclic Compounds; Hot Temperature; Humans; Liver Neoplasms; Macaca fascicularis; Meat; Mutagens; Poultry; Primates; Quinolines; Quinoxalines; Tissue Distribution | 1995 |
Studies on the carcinogenic and myocardial effects of 2-amino-3-methylimidazo [4,5-f] quinoline (IQ) in nonhuman primates.
Topics: Administration, Oral; Animals; Carcinogens; Cooking; DNA Adducts; Fibrosis; Heart; Hot Temperature; Humans; Imidazoles; Inflammation; Liver Neoplasms; Liver Neoplasms, Experimental; Lung Neoplasms; Macaca fascicularis; Meat; Myocardium; Necrosis; Quinolines; Quinoxalines | 1995 |
Genotoxic effects of heterocyclic aromatic amines in human derived hepatoma (HepG2) cells.
Topics: Amines; Animals; Arylamine N-Acetyltransferase; Carbolines; Carcinogens; Carcinoma, Hepatocellular; Cell Line; Cell Survival; CHO Cells; Cricetinae; Heterocyclic Compounds; Humans; Imidazoles; Liver Neoplasms; Mutagenicity Tests; Mutagens; Quinolines; Quinoxalines; Rats; Salmonella; Tumor Cells, Cultured | 1999 |
Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
Topics: Animals; Body Weight; Carbolines; Carcinogens; Drug Synergism; Enzyme Induction; Glutathione Transferase; Imidazoles; Immunohistochemistry; Liver; Liver Neoplasms; Male; Organ Size; Quinolines; Quinoxalines; Rats; Rats, Inbred F344 | 1991 |
Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Topics: Animals; Clitoris; Female; Food; Genital Neoplasms, Female; Hot Temperature; Liver Neoplasms; Male; Neoplasms, Experimental; Quinoxalines; Rats; Rats, Inbred F344; Skin Neoplasms | 1988 |